CAP President Donald S. Karcher, MD, FCAP, and Engaged Leadership Network member, discussed laboratory-developed tests and Medicare cuts. “Most pathology labs have LDTs on their menu, and immunohistochemical LDTs are common, if not the most common, test in those labs,” said Dr. Karcher.
For the full article click here: CAP Lobbying for Relief on LDTs, Medicare Cuts
